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Abstract: Lyme disease (LD) is a complex, multisystemic illness. As the most common 
  vector-borne disease in the United States, LD is caused by bacterial spirochete Borrelia 
  burgdorferi sensu stricto, with potential coinfections from agents of anaplasmosis, babesiosis, 
and ehrlichiosis. Persistent symptoms and clinical signs reflect multiorgan involvement with 
episodes of active disease and periods of remission, not sparing the coveted central nervous 
system. The capability of microorganisms to cause and exacerbate various neuropsychiatric 
pathology is also seen in pediatric autoimmune neuropsychiatric disorders associated with 
streptococcal infections (PANDAS), a recently described disorder attributed to bacterium 
Streptococcus pyogenes of group A beta-hemolytic streptococcus in which neurologic tics and 
obsessive-compulsive disorders are sequelae of the infection. In the current overview, LD and 
PANDAS are juxtaposed through a review of their respective infectious etiologies, clinical 
presentations, mechanisms of disease development, courses of illness, and treatment options. 
Future directions related to immunoneuropsychiatry are also discussed.
Keywords: neuroborreliosis, infection, obsessive-compulsive disorder, tic disorder, Borrelia 
burgdorferi, strep throat
Introduction
Lyme disease (LD) and pediatric autoimmune neuropsychiatric disorders associated 
with streptococcal infections (PANDAS) are mutually exclusive disease states which 
share similarities but also important differences. Symptomatic overlap of LD and 
PANDAS raises the question of whether misdiagnoses may occur. Correct initial 
assessment is important since treatment for each may differ and delay may result in 
worsening symptoms, as evidenced in LD.1,2 In this current overview, LD and PAN-
DAS are juxtaposed through a review of their respective infectious etiologies, clinical 
presentations, mechanisms of disease development, courses of illness, and treatment 
options. Future directions related to immunoneuropsychiatry are also discussed.
LD is attributed to infection from Borrelia burgdorferi and potential coinfections 
transmitted to humans via the Ixodes scapularis tick bite.3 A recent report from the Centers 
for Disease Control and Prevention (CDC)3 shows an annual increase of reported cases 
despite increased public awareness and preventative measures. From 1992 to 2006, most 
reported cases occurred during the summer months; average annual rates peaked for 5- to 
9-year-olds and for 55- to 59-year-olds, with rates increasing disproportionately among 
males. Proportion of cases developing disseminated disease states has not decreased.3 
Additionally, natural history and epidemiology of coinfections are not fully known, and 
some clinicians may have limited experience in recognizing and managing them.4
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PANDAS is attributed to the relatively abrupt onset and 
recurrence of pediatric obsessive-compulsive disorders 
(OCD) and neurologic tic disorders (as defined by the out-
dated Diagnostic and Statistical Manual of Mental   Disorders: 
DSM-IV [DSM-IV®]5 criteria) following bacterial infection 
  Streptococcus pyogenes of group A beta-hemolytic strepto-
coccus (GAβHS). Sore throat and flu-like symptoms often 
precedes the neuropsychiatric sequelae. Five diagnostic cri-
teria, outlined in Table 1, are needed to diagnose PANDAS.6,7 
Incidence per 100 child-years of acute sore throat, GAβHS 
swab-positive pharyngitis, and serologically confirmed 
GAβHS pharyngitis were 33, 13, and 8, respectively, in 5- to 
12-years-olds according to one study.8,9 Overall prevalence or 
percentage of infected children who then develop PANDAS is 
not yet known. It was first described in a landmark study by 
Swedo and Grant7 in 1998 but since its inception, PANDAS 
has become a controversial subject in the medical literature 
and across the Internet.10–12
The bacteria
Understanding LD and PANDAS begins with knowledge of 
their respective infectious agents. Although B. burgdorferi 
and GAβHS are vastly different microorganisms, their ability 
to evade the immune system and invade a wide variety of 
tissues, including the coveted central nervous system (CNS), 
is a paradigm of survival. The mechanism with which it then 
results in diverse somatic symptoms and neuropsychiatric 
sequelae underscores the need for experienced clinicians, 
laboratory testing, and early treatment.
LD is caused by an infection from the bacterial spiro-
chete B. burgdorferi and potential coinfections from agents 
of   anaplasmosis, babesiosis, and ehrlichiosis carried by the 
primary tick vector Ixodes scapularis, which bites its human 
host to transmit microorganisms.4,13,14 The white-footed mouse 
is a commonly cited B. burgdorferi host, but at least ten other 
wild and domestic mammalian   species harbor B. burgdorferi, 
including dogs, horses, cows, rabbits, and   raccoons.15   Various 
species of Borrelia with numerous antigenic heterogeneity 
have been implicated in LD.13,14 B.   burgdorferi was initially 
isolated and described in the 1970s during an epidemic of 
pediatric arthritic cases in the northeastern United States 
(US);16,17   however, similar descriptions have been observed in 
Europe since the 1800s.18,19 Today B. burgdorferi is reported 
  worldwide, possibly distributed via migratory birds.20,21
B. burgdorferi is a pleomorphic bacterial spirochete 
enclosed in a cell cylinder covered with multiple periplasmic 
flagella, surrounded by an outer membrane sheath;22 it exists in 
elongated, atypical, or cystic forms.23 After the tick bite injects 
B. burgdorferi and potential coinfections into the host, ideally 
the innate immune cells engulf the spirochete, digesting it 
enzymatically, which generally succeeds in killing the invading 
organisms. However, an unknown number of B.   burgdorferi 
may survive for days and even weeks after initial infection and 
continue the invasion, evading humoral immunity possibly by 
manipulating antigenic surface proteins or a weakened host 
immune response.24–26 B. burgdorferi has not yet been found 
to cause tissue damage by releasing toxins or proteases itself, 
but may in fact over-activate the host immune system, which 
may then lead to inflammation and tissue damage. Significance 
of B.   burgdorferi adhesive properties with regard to host cells 
has also been reported.27 Cellular immunity and secretion of its 
factors have been well characterized in the murine model, but 
the exact mechanism in humans is not well known.26
GAβHS in PANDAS is a spherical, Gram-positive, non-
motile organism and the most common bacterial cause of acute 
pharyngitis (“strep throat”) in children.9,28   Numerous sero-
types of GAβHS have varying degrees of disease   activity with 
classification based on antigenic surface proteins M and T. 
They are the infectious agents of scarlet fever, acute rheumatic 
fever (ARF), glomerulonephritis, toxic shock syndrome, and 
necrotizing fasciitis, amongst others. Its armament of anti-
genic surface proteins and pyrogenic exotoxins, as well as 
its ability to lyse its way systemically and evade the immune 
system effectively, have been well   characterized. M protein, 
for example, is the major virulence factor preventing phago-
cytosis, multiplying rapidly in human tissue and initiating the 
disease process. More than 80 types of S. pyogenes M proteins 
alone have been isolated.29 The serotype(s) in PANDAS is not 
yet known. GAβHS is generally spread by direct personal con-
tact, most likely through droplets of saliva or nasal secretions. 
Crowding increases transmission, and outbreaks are common 
through chronic asymptomatic carriers and in institutional 
settings, such as the military, daycare centers, and within 
households. Human contamination of food has also been 
Table 1 Diagnostic criteria for PANDAS (pediatric autoimmune 
neuropsychiatric  disorders  associated  with  streptococcal 
infections)5,6
Criteria
1. OCD and/or neurological tic disorder (met by DSM-IV®5 criteria)
2. Onset before puberty
3.   Clinical course is episodic with acute, severe onset; symptom 
exacerbations are dramatic
4. During symptom exacerbations, neurological abnormalities are present
5. GAβHS infection and symptom exacerbations occurring temporally
Abbreviations:  DSM-IV®,  Diagnostic  and  Statistical  Manual  of  Mental  Disorders: 
DSM-IV;  GAβHS,  group  A  beta-hemolytic  streptococcus;  OCD,  obsessive-
compulsive disorder.
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reported.30–32 Resurgence of invasive   streptococcal diseases 
and the continued presence of ARF in the US   predicates 
continued surveillance.33,34
Somatic signs and symptoms
The somatic clinical course of LD and PANDAS share 
notable characteristics. Both may cycle between episodes 
of active disease and periods of quiescence. Distinctions 
between the two may also be made (Table 2).
B. burgdorferi may spread systemically localizing in 
somatic regions such as skin and joints,23,35,36 but can also 
maintain the ability to remain in a dormant, remissive 
state sequestered in collagen tissues, evading the immune 
  system.37 Successful immune response clears the infection, 
but continued activation due to persistent infection may 
lead to chronic inflammation, lesion development, and 
subsequent multisystemic disease formation.38,39 Arthritis, 
for example, is generally attributed to chronic neutrophilic 
activation, whereas carditis is associated with macrophytic 
and T lymphocytic activities in murine studies.40,41
Somatic signs and symptoms in LD children resemble 
those seen in adults.42 Findings most commonly reported 
to the CDC were erythema chronicum migrans (ECM), 
arthritic, neurologic, and cardiac abnormalities. Early 
stages may   present with ECM, which is often described as 
a “bull’s-eye” rash, but the CDC reports 31% had none.3 
Variability in gross appearance of ECM has also been 
noted, including homogeneous erythema, multiple annular 
lesions, and vesicular or centrally-ulcerated dermal pathol-
ogy.43,44 Aucott et al46 reported misdiagnoses occurred with 
greater frequency in patients with objective extracutane-
ous manifestations without ECM than in patients with 
ECM (83% vs 23%; P = 0.004). LD rashes were most 
often misdiagnosed as cellulitis, spider bites, or shingles. 
Of misdiagnosed cases, 41% received antibiotics not recom-
mended for LD treatment and 30% were given steroids46 
which have been shown to decrease patient response to 
antibiotics.47 Additionally, number of ECM or the disap-
pearance of rash may not be indicative of disseminated 
state of disease.48,49
Other LD somatic signs and symptoms may include 
fatigue, arthralgia(s), cardiopathy, hepatitis, or splenom-
egaly.50,51 Patients may also present with flu-like symptoms 
such as sore throat, nonproductive cough, fever and chills, 
or lymphadenopathy. Somatic disease may also be migra-
tory and episodic over several weeks.50 Of note, children 
over 10 years of age with arthritis and cardiopulmonary 
symptoms were more likely to be diagnosed with carditis.52 
LD children with arthralgias have been misdiagnosed with 
septic arthritis or   juvenile rheumatoid arthritis, resulting in 
delayed treatment.53 Of patients who do not receive proper 
early treatment, more than half may go on to develop recur-
rent arthralgias,16 and children may not receive proper treat-
ment for over a year.54
In contrast to LD, somatic signs and symptoms of 
  PANDAS may begin as streptococcal pharyngitis or “strep 
throat” which may later manifest as OCD or neurologic tics.6 
Pharyngitis may also present with a fever greater than 38°C 
and with cervical lymphadenopathy. Examination of oral 
mucosa may show erythema or exudates present on tonsil-
lopharyngeal regions along with palatal petechiae.32 Reports 
of children with stomach pains, emesis, and other upper respi-
ratory illnesses such as new-onset asthma, sinus infections, 
and severe recurrent ear infections have also been noted.32,55 
Although GAβHS is reportedly a cause of acute pharyngitis 
in up to 30% of children,9 viral or other bacterial etiologies 
may need further consideration.
Neuropsychiatric signs and 
symptoms
Symptomatic presentation of LD and PANDAS may cross 
paths in the nervous system. From the original port of entry, 
Table 2 General clinical presentations
Sign/symptom LD PANDAS
Flu-like symptoms +++a +++
Lethargy +++ ++
Rash ++ NS
Sore throat ++ +++
Other upper respiratory infection ++ ++
Arthralgia +++ NS
Carditis ++ NS
Enuresis NS ++
Headache +++ ++
Neuropathies +++ +++
Choreiform movements NS +
Neurological tics + +++
Mood disturbances +++ +
Psychosis + +
Obsessions/compulsions + +++
Hyperactivity + ++
Problems concentrating +++ +++
Separation anxiety + ++
Handwriting changes + ++
Decline in school performance +++ +++
Suicidal ideations + NS
Homicidal ideations NS +
Note: aNumber of “+” symbols denotes relative reporting in referenced publications.
Abbreviations:  LD,  Lyme  disease;  NS,  not  significant;  PANDAS,  pediatric 
autoimmune neuropsychiatric disorders associated with streptococcal infections.
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whether it be punctured epidermis or upper respiratory tract, 
invading microorganisms may make their way systemically, 
potentially resulting in neuropsychiatric pathology impacting 
the child’s quality of life, school performance, and relation-
ships with family and friends. Untreated LD may develop 
neurologic sequelae in up to 15% of cases.56
In LD, the mechanism B. burgdorferi utilizes to evade 
immune defenses and enter the nervous system has been the 
focus of intense research. Differences in disease severity57 
have been attributed to genomic variations of bacterial strains58 
or host responses as observed in murine models.41 Animal stud-
ies have shown spirochete load is not associated with severity 
of illness59,60 suggesting B. burgdorferi may not be directly 
involved in neuronal damage. Spirochetes have also been 
observed localized in collagenous areas and along perivascular 
spaces in the human brain.1 Entry of B. burgdorferi into the 
CNS may be attributed to its adherence along the endothe-
lial lining of blood vessels resulting in an immune response 
releasing cytokines, initiating fibrinolysis, and recruiting 
leukocytes, causing damage to the blood–brain barrier. Other 
recent studies have suggested, at least in part, ligand-gated or 
paracellular routes of transmigration without endothelial base-
ment membrane pathology.61–65   Groundbreaking in vivo murine 
studies by Norman et al66 and Moriarty et al67 used genetically 
engineered fluorescent B. burgdorferi strains expressing green 
fluorescent proteins to visualize their movements. They filmed 
in real time B. burgdorferi glowingly tether, drag, and adhere 
to the vessel wall of endothelium along much of their length. 
In addition, stationary adhesions were usually followed by 
extravasations at intercellular junctions.66,67 In humans, cortical 
regions sans blood–brain barrier include the posterior pituitary 
gland (site of hormones oxytocin and vasopressin release), 
pineal gland (site of hormone melatonin release and control 
of circadian rhythm), median eminence of the hypothalamus 
(site of pituitary hormones release), and the area postrema 
(site eliciting nausea and vomiting in response to serum tox-
ins).68 But, because murine brain lacks collagen, relevance 
to human pathology may be limited.1
Within the cerebral cortex, pleomorphic B. burgdorferi 
may also exist in alternate forms, possibly explaining a 
prolonged latent stage and persistent infection in neurobor-
reliosis. Using atomic force and dark-field microscopy in 
postmortem studies of patients with chronic Lyme neurobor-
reliosis, Miklossy et al23 collaborated with the US Army to 
photograph atypical and cystic states which were then success-
fully cultured in growth media. Weis et al69 attributed cellular 
damage to robust induction of cytokines by B. burgdorferi 
antigens, up to 500-fold greater than Escherichia coli. 
Evidence suggests macrophages of innate immunity 
ingest B. burgdorferi, activate cellular immunity, and 
through cytosolic signaling undergo programmed cell 
death.70 Ramesh et al71,72 studied ex vivo and in vivo nonhu-
man primates stereotactically infected with B. burgdorferi 
directly into the brain. Their findings suggest B. burgdor-
feri induces inflammatory mediators leading to glial and 
neuronal apoptosis consistent with the bystander effect. 
Neuronal and Schwann cell apoptosis in dorsal root ganglia 
may be a mechanism whereby B. burgdorferi affects the 
peripheral nervous system as well. Subsequent research 
by Myers et al73 confirmed proinflammatory cytokines 
released from resident microglia were implicated as media-
tors to neuronal apoptosis via the p53 pathway. However, 
antineuronal antibodies suggestive of molecular mimicry 
have also been debated.74–76 Interestingly, Newell et al77 
concluded rogue nonantigen-primed B-cell proliferation 
failing to apoptose after TLR-dependent B-cell polyclonal 
activation may be a mechanism to chronic inflammation. 
Genetic MHC variants in patients may determine T-cell 
receptor-dependent B-cell death.77 Development of anti-
neuronal antibodies from renegade B cells associated with 
B. burgdorferi patient-human leukocyte antigen (HLA) 
haplotyping is not yet known.
Neurologic pathology in children resulting from B. burg-
dorferi infection is wide-ranging. The majority of young 
patients do not develop problems if treated promptly and 
appropriately; however, B. burgdorferi has been observed to 
exhibit CNS dissemination within 2 weeks of active disease.78 
A study of LD children by Belman et al79 reported the most 
frequent symptom was headache and the most common sign 
was facial palsy. Less common were sleep disturbances and 
papilledema associated with increased intracranial pressure; 
peripheral nervous system involvement was infrequent.
Other findings were mild encephalopathy, lymphocytic 
meningitis, and cranial neuropathy, as well as anecdotal 
reports of pseudotumor cerebri-like disease.80
LD psychiatric manifestations such as behavioral changes 
and memory deficits may have its greatest impact on school 
performance and quality of life. Intellectual functioning may 
be normal but auditory or visual sequential processing pathol-
ogy have been reported.81–83 In a well-designed controlled 
study investigating cognitive impairment in children having 
already received antibiotic therapy (previous medication type, 
dose, and treatment duration not reported), a significant num-
ber continued to experience problems. Neurocognitive testing 
revealed frequent and severe headaches (100%), brain fog 
(88%), short-term memory loss (94%),   word-finding problems 
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(82%), distractibility (82%), schoolwork   deterioration (94%), 
irritability/depression (94%), insomnia (82%), and sensitivity 
to sound (58%) and/or light (74%).54 Another study reported 
LD children with oppositional behavior, anxiety disorders, 
and attention-deficit/hyperactivity disorder (ADHD).82 Of 
special interest, a report by Riedel et al84 described an LD 
child presenting with Tourette’s syndrome, a neurologic tic 
disorder also seen in PANDAS, which resolved with antibiotic 
treatment. Although psychiatric manifestations of pediatric 
LD appear to have little or no mortality risk, Tager et al54 
reported 40% had suicidal thoughts and parents indicated 
11% “had made a suicide gesture.”   However, larger, more 
in-depth studies are needed to better assess suicide risk in 
this patient population.
GAβHS infection in PANDAS is a well-characterized 
bacterium implicated in other neuropsychiatric disease 
states.85–87 In the case of PANDAS, passive antibody trans-
fer in murine models,88 maternal history of autoimmune 
disease,89 and reports of positive antineuronal antibodies in 
patient sera90 suggest molecular mimicry, at least in part, as 
a cause of disorder development.
Movement of immune products into the CNS has been 
illustrated in animal   models. In mouse studies of nascent 
autoimmune CNS lesions, Bartholomäus et al91 filmed in 
real time effector T cells   trekking their way upstream against 
tides of vascular flow and their subsequent diapedesis across 
the blood–brain barrier whereupon encountering microglia 
presenting antigen. Stimulated effector T cells then produced 
proinflammatory mediators, resulting in tissue invasion and 
inflammatory infiltration. Lipopolysaccharide epitopes or 
ligand epinephrine may alter permeability, allowing cellular 
immunity to penetrate into the brain.92 Once inside the cere-
bral cortex, antibodies may also cross-react with neuronal 
cells. Kirvan et al90 reported antibodies from PANDAS serum 
reacted in vitro with caudate and putamen neuronal lyso-
ganglioside GM1, inducing calcium/calmodulin-dependent 
protein (CaM) kinase II activity. Removal of immunoglobu-
lins from patient serum extinguished CaM kinase II cell 
signaling, and cerebrospinal fluid (CSF) reactivity was then 
successfully blocked by GAβHS cell wall epitope N-acetyl-
beta-D-glucosamine.
Resulting neuropsychiatric pathology seen in PANDAS 
meeting the 1998 criteria7 is episodic and acute OCD and/
or neurologic tics (defined by the outdated DSM-IV®5 crite-
ria) in temporal relation with GAβHS infection. Generally 
well-adjusted children may develop changes within days 
and resolution up to 8 weeks later.93 However, the summa-
rized definition of OCD as defined by the DSM-IV-TR®,94 
the latest version of the manual replacing the DSM-IV®,5 
are recurrent and persistent thoughts, impulses, or images 
which are intrusive and inappropriate, causing distress and 
anxiety beyond excessive worries about real-life problems. 
Children may attempt to ignore, suppress, or neutralize 
them with other thoughts or actions. Resulting compulsions 
are repetitive behaviors or mental acts performed ritualisti-
cally in response to obsessions, the purpose of which is to 
prevent or reduce distress or actions. Importantly, there is 
no logical cause and effect relationship between obsessions 
and compulsions. Children would not necessarily have 
insight into their pathology which can be time consuming 
and may interfere with normal daily activities.94 An example 
of this is a child who brushes his teeth exactly ten strokes 
several times daily, believing it keeps the wind from blow-
ing his parents away. The most current DSM-IV®-TR defines 
Obsessive-Compulsive Disorder as not having disturbances 
attributed to a general medical condition (300.3). Therefore 
most appropriate diagnosis may be Anxiety Disorder Due 
to [Streptococcal Infection], with Obsessive-Compulsive 
Symptoms (293.84) which also requires clinical coding on 
Axis III of the multiaxial diagnostic assessment.
In the case of neurologic tic disorders, they are defined as 
vocal or motor repetitions which are rapid, sudden, repetitive, 
nonrhythmic but stereotyped (eg, eye blinking, coughing, 
sniffing, throat clearing). They may occur multiple times 
daily for many weeks or cycles. Tourette’s disorder (307.23), 
Chronic Motor or Vocal Tic Disorder (307.22), and Transient 
Tic Disorder (307.21) exclude general medical conditions. 
Therefore, most appropriate diagnosis may be Tic Disorder 
Not Otherwise Specified (307.20)94 with congruent Axis III 
coding. The American Psychiatric Association established 
a task force to update and release the new DSM-5 in 2013.95 
Definition of general medical condition may need further 
clarification.
PANDAS characteristics not generally seen in OCD 
alone have been reported. A study by Bernstein et al96 found 
urinary urgency, hyperactivity, impulsivity, deterioration in 
handwriting, separation anxiety, and decline in school per-
formance as significant traits in the initial neuropsychiatric 
episode. Other traits in the sentinel event included inatten-
tion, mood swings, and oppositional defiant behavior. Most 
common obsessions were aggression and contamination, 
and most common compulsions were washing, cleaning, 
and checking rituals. Most common symptoms associated 
with exacerbations were labile emotions, decline in school 
performance, personality change, bedtime fears/rituals, and 
restlessness. In addition, motor hyperactivity and adventitious 
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movements were not infrequently reported and should   
be distinguished from Sydenham’s chorea, a criterion for ARF 
which necessitates antibiotic treatment because of its associa-
tion with endocarditis. Use of prophylactic antimicrobials in 
PANDAS remains controversial.7,97
An interesting case of an 8-year-old boy with PANDAS 
who developed OCD and an eating disorder was recently 
described. When asked about his ritualistic behavior, the child 
replied, “it helps me to relax. It distracts me from the images 
in my head.” Statements of his internal running monologues 
were “you must do the hand thing before you eat or the food 
will poison you,” and “your mommy is a criminal and con-
taminating your favorite things.” The child only walked on 
his father’s right-hand side so as “not to give off fat cells to 
people walking by.” He later developed ritualistic behaviors 
such as finger snapping to “undo contamination.” The boy 
also developed signs of paranoia, believing hospital staff were 
“evil” and trying to poison him. He recognized these fears 
were not real but coming from his imagination.98 Another 
report described a child with PANDAS who experienced 
catatonic episodes but whose cognition, comprehension, 
and receptive language were otherwise intact. Subsequent 
magnetic resonance imaging showed swelling in both the 
caudate and the putamen with disruption of the blood–brain 
barrier resulting in vasogenic edema.99 Reports of children 
having homicidal thoughts directed against their parents and 
others55 may require further investigation.
Laboratory testing and  
radiographic studies
Objective laboratory testing may be of benefit in distin-
guishing between LD and PANDAS and in differential 
  diagnosing. Although LD is a clinical assessment, enzyme-
linked immunosorbent assay (ELISA) and Western blots can 
confirm diagnoses but may not be necessary for patients with 
ECM.100 For those without dermal pathology, diagnoses by 
experienced LD clinicians, in conjunction with high-quality 
laboratory testing, are important to prevent treatment delays. 
CSF studies have also been examined101–103 but with anec-
dotal reports of LD misdiagnosed as malignancies,80 a high 
index of suspicion from experienced LD clinicians remains 
the gold standard.
In the case of PANDAS, confirmation of GAβHS infec-
tion is generally performed with the rapid antigen detection 
test (RADT) in the physician’s office. However, throat 
culture is considered the gold standard and may require up 
to 2 days for confirmation. Modified Centor scoring9,104 and 
McIsaac scoring105 approaches to management have been 
utilized. Both have similar sensitivities of over 85% and 
even higher specificities.9 Interestingly, the sensitivity of 
RADT may not be a fixed value but may vary with disease 
severity. Even among pediatric patients with a high Centor 
score, sensitivity of RADT remains too low to support the use 
of RADT without culture confirmation of negative results.106 
Ancillary studies such as serologies of antistreptolysin O and 
deoxyribonuclease-B antibodies,7,96,99,107–110 CSF from lumbar 
puncture,98,109,110 and radiographic findings6,7,99,111–114 have 
also been helpful in differential diagnosing but may not be 
required in fulfilling criteria for PANDAS.6,7
Treatment
Primary treatment for children with LD utilizes antimicrobials 
in various doses, durations, and routes of administration.115–118 
LD may be refractory to initial care because of coinfections, 
incorrect diagnoses, improper medications, or patient genetic 
variations.56,82,119,120 Treatment delays may compromise 
patient care. According to one study, average number of 
physicians consulted before correct diagnosis was 3.80, and 
mean time from parent-reported symptom onset to diagnosis 
was 47.3 weeks.54
Primary treatment for PANDAS has been less clear. 
Since its establishment as a subcategory of GAβHS-induced 
neuropsychiatric disorder remains controversial, protocols 
are provisional at best. Irregardless of PANDAS diagno-
sis, children with evidence of GAβHS infection based on 
clinical scoring systems or objective testing may neces-
sitate antibiotic use to prevent disseminated disease states 
such as ARF.9,121 In the case of PANDAS, antibiotic treat-
ment alone may be efficacious.122 Prophylactic use remains 
controversial.95,123 Aside from medications, reports of intrave-
nous immunoglobulin (IVIG) or plasma exchange have also 
been noted.97,124,125 In one study, double-blind, randomized 
controlled trials of IVIG, plasma exchange (not blinded), 
or placebo showed statistically significant improvements 
in obsessive-compulsive behaviors, neurologic tics (plasma 
exchange only), global impairment, anxiety, global sever-
ity, and emotional lability. However, longitudinal studies 
with longer follow-up are needed to determine remission 
rates or rebound effects.124 Surgery for adenoid and tonsil 
removal alone or in combination with medications may also 
be effective.55,98,113,126,127
Secondary support for both LD and PANDAS may 
include use of psychotropics, therapy, education, and 
accommodations. Medications for OCD, neurological tics, 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
168
Rhee and CameronInternational Journal of General Medicine 2012:5
depression, anxiety, and ADHD have shown to benefit 
  children and may not be required long-term.110,128,129 Cognitive 
behavioral therapy,130,131 supportive therapy, and academic 
  accommodations are also useful. In the US, Individuals 
with Disabilities Education Act, Individualized Education 
Program, and Section 504 of the Rehabilitation Act of 1973 
have been mobilized for LD schoolchildren to achieve their 
academic goals. Other educational assistance includes shorter 
school days, untimed tests, alternative testing methods, 
separate/quieter testing locations, modified home instruction 
programs, and elimination of unnecessary requirements.132
Future directions
We have presented the first overview of both LD and 
  PANDAS detailing microbial etiology, disease development, 
clinical overlap, and treatment options. Although LD as a 
clinical diagnosis is relatively established, PANDAS as a 
distinct subgroup remains controversial. GAβHS infection 
occurring temporally with OCD or neurologic tics may be 
coincidental, given the high incidence of GAβHS in this age 
group, and symptom etiology or exacerbation may be due 
to stress of the illness versus the infection itself.6 However, 
PANDAS research suggestive of molecular mimicry, clini-
cal improvement with IVIG or plasmapheresis, and lack of 
cardiac involvement supports the existence of PANDAS as 
a distinct subgroup of GAβHS-induced neuropsychiatric 
disorders.112,113,133,134 Inconsistencies in defining PANDAS 
may preclude development of treatment protocols and com-
parison between studies. Quantifying temporal timelines 
between infection and symptomatic presentation may also 
serve to standardize research protocols. Incorporating the 
most current DSM may update the PANDAS definition but 
could also redefine PANDAS itself.
Other possible investigative directions may include adult 
PANDAS,108,114,135 familial occurrences,107,136 or various infec-
tious etiologies such as Mycoplasma, which has also been 
associated with OCD, Tourette’s syndrome, parkinsonism, 
and dystonia.137–139  Differential and working diagnoses need 
continued consideration11,111 since not all symptom exacer-
bations are preceded by GAβHS infections; viral infections 
or other illnesses could also trigger worsening of symptoms 
according to one study.7
In the interesting case of a 4-year-old boy with LD who 
developed a motor tic (eye blinking) coinciding with increased 
IgG titres for B. burgdorferi on ELISA, the child subsequently 
improved with antibiotic therapy. Infection with B. burgdor-
feri should be considered in cases of Tourette’s syndrome 
in endemic areas, according to one author.84 However, 
a detailed description of the boy’s initial   clinical   presentation 
was lacking and GAβHS testing was not mentioned. This may 
be attributed to publication   coinciding with the first PANDAS 
study,7 both having occurred in February 1998.
Overlap between LD and ARF may warrant further 
  discussion. The latter may also present with an annular “bull’s-
eye” lesion termed erythema marginatum rheumaticum 
(EMR)140 grossly similar to that seen in LD.52,100,141 Definitive 
diagnosis may be confirmed by punch biopsy and histologic 
studies.43,140,142 Carditis, also observed in   pediatric LD,52,143–145 
and EMR are two major criteria in ARF diagnosis.146,147 Migra-
tory arthritis usually involving large joints is often described in 
LD100,148,149 and is also, coincidentally, a third major criterion 
in ARF.146,147
Immunoneuropsychiatry has brought forth a plethora 
of questions regarding the immunomolecule effect on the 
human mind. Current research suggests anti-neuronal rather 
than antimicrobial vaccine development for HLA haplotypes 
may be of future interest. However, the ubiquitous MHC-I 
molecule was recently found to possibly regulate synaptic 
density during development in murine studies and to affect 
balance between excitatory and inhibitory plasticity in 
nascent neurons, a property critical for information process-
ing in young brains.150 The potential to improve mentation 
with administration of anti-inflammatory medications would 
also be of future interest. Minocycline, a bacteriostatic tet-
racycline derivative with lipophilic properties and relatively 
high CNS penetration, has been extensively investigated as 
an inhibitor of apoptosis.115,151–159 Its use in treating nega-
tive signs and symptoms of schizophrenia has also shown 
benefit.160–162 Interestingly, a correlation between sporadic 
clusters of schizophrenia and seasonal distribution of Ixodes 
ticks attributed causality with intrauterine exposure to B. 
burgdorferi.163,164 The American College of Rheumatology 
supports use of minocycline as a disease-modifying antirheu-
matic drug,165 irrespective of infectious etiology. Long-term 
minocycline use for its CNS-penetrating, anti-inflammatory 
effects in children over the age of 8 with “antibiotic-
refractory (or slowly resolving) Lyme arthritis”166 would be 
of significant interest in future studies, allowing opposing 
viewpoints166,167 to claim victory and, most importantly, for 
children to receive proper treatment.
Recognition and validation of LD has come a long way 
since the essay ridiculing “Lime” patients was first published 
in Annals of Internal Medicine.82,168 Astute parents part-
nered with experienced clinicians make a formidable team 
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in addressing the pediatric patient and treatment course. 
As families attempt to receive care for their children, it is 
hoped they would not face ridicule from the medical com-
munity as well.
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